Dinh Thiem V, Van Anh PT, Van Men C, Hung DT, et al. A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial. Vaccine 2024 May 10:S0264-410X(24)00523-1. doi: 10.1016/j.vaccine.2024.
PMID: 38734495